DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2026
    • Delegate Registration
    • Programme Preview
    • The DDL Incubator
    • Attending Exhibitors and Sponsors
    • Exhibition & Sponsorship Opportunities
    • New Researcher Network
    • Hotel and Travel
    • Call for Papers
    • Media Partners
    • Frequently Asked Questions
  • Archive
    • Conference Papers Archive
    • DDL2025
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • EPAG Workshop
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2024
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2023
      • Lecture Recordings
      • The Association of Inhalation Toxicologists – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2022
      • Lecture Recordings
      • Academy of Pharmaceutical Sciences – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2021
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Sponsors
    • Previous Years Conferences
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
    • Aerosol Society Awards
  • About
    • Gallery
    • History
    • DDL Charter
    • Committee
    • The Scientific Advisors
    • Contact
  • Associated Events
    • Annual Aerosol Science Conference
    • RDD 2027
  • The Aerosol Society logo
Chris Gruenloh

Chris Gruenloh

PPD, part of Thermo Fisher Scientific

Paper: Plume Geometry: examination of processing schemes and inter-analyst variability…We Can Do Better!

Download Paper

Chris is a Research Fellow in the GMP lab of the PPD clinical research business of Thermo Fisher Scientific, where he supports development and implementation of analytical solutions for clients who are developing OINDPs and other drug-device (e.g., pre-filled syringes and autoinjectors) combination products. Prior to joining the clinical research business in 2015, Chris worked at GlaxoSmithKline (1999 to 2015), where he led analytical and CMC teams developing small molecule, oligonucleotide and peptide-based therapeutics for treatment of asthma, COPD and metabolic diseases. Chris’ research interests include delivery of biologics to the respiratory tract and better controlling sources of variability impacting OINDP testing platforms. Chris has B.S. degree in chemistry from St. Louis University and a Ph.D. in analytical chemistry from Purdue University.

Video of Chris Gruenloh

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2026 Drug Delivery to the Lungs Website design: definingdesign.co.uk